In Reply to Hannoun-Levi and Hannoun

Affiliations

Comment

Krishan R Jethwa et al. Int J Radiat Oncol Biol Phys. 2019.

. 2019 Aug 1;104(5):1177-1179.

doi: 10.1016/j.ijrobp.2019.04.017. Epub 2019 Apr 27.

No abstract available

Conflict of interest statement

Conflicts of Interests: None.

Three-Fraction Intracavitary Accelerated Partial Breast Brachytherapy: Early Provider and Patient-Reported Outcomes of a Novel Regimen.
Jethwa KR, Park SS, Gonuguntla K, Wick SM, Vallow LA, Deufel CL, Whitaker TJ, Furutani KM, Ruddy KJ, Corbin KS, Hieken TJ, Mutter RW. Jethwa KR, et al. Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):75-82. doi: 10.1016/j.ijrobp.2018.12.025. Epub 2018 Dec 21. Int J Radiat Oncol Biol Phys. 2019. PMID: 30583041 Free PMC article.
In Regard to Jethwa et al.
Hannoun-Levi JM, Hannoun A. Hannoun-Levi JM, et al. Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1176-1177. doi: 10.1016/j.ijrobp.2019.04.018. Epub 2019 Apr 27. Int J Radiat Oncol Biol Phys. 2019. PMID: 31039419 No abstract available.

1. Jethwa KR, et al., Three-Fraction Intracavitary Accelerated Partial Breast Brachytherapy: Early Provider and Patient-Reported Outcomes of a Novel Regimen. Int J Radiat Oncol Biol Phys, 2018. - PMC - PubMed
1. Haynes AB, et al., Timing of infectious complications following breast-conserving therapy with catheter-based accelerated partial breast irradiation. Ann Surg Oncol, 2014. 21(8): p. 2512–6. - PubMed
1. Cuttino LW, et al., Long-term results from the Contura multilumen balloon breast brachytherapy catheter phase 4 registry trial. Int J Radiat Oncol Biol Phys, 2014. 90(5): p. 1025–9. - PubMed
1. Vicini F, et al., Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys, 2011. 79(3): p. 808–17. - PubMed
1. Wilkinson JB, et al., Four-year results using balloon-based brachytherapy to deliver accelerated partial breast irradiation with a 2-day dose fractionation schedule. Brachytherapy, 2012. 11(2): p. 97–104. - PubMed